When did the requirement for a DOCTYPE declaration in Sequence Listing XML become effective?
Source: FAQ (MPEP-Based)BlueIron Update: 2024-09-29
This page is an FAQ based on guidance from the Manual of Patent Examining Procedure. It is provided as guidance, with links to the ground truth sources. This is information only: it is not legal advice.
The requirement for a DOCTYPE declaration in Sequence Listing XML became effective for patent applications filed on or after July 1, 2022. As stated in MPEP 2413.01(d):
This section is applicable to all applications filed on or after July 1, 2022, having disclosures of nucleotide and/or amino acid sequences as defined in 37 CFR 1.831(b).
This change aligns with the implementation of WIPO Standard ST.26 for sequence listings in patent applications.
Topics:
MPEP 2400 - Biotechnology
MPEP 2413.01(D) - The "Sequence Listing Xml" Must Contain A Doctype Declaration
Patent Law
Patent Procedure